27 02, 2023

Seagen Jumps 11% on Pfizer Acquisition Rumors – Should You Buy the Hype Early?

By |2023-12-07T21:00:34+00:00February 27th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , , |

As Pfizer’s sales continue to struggle, they’ve turned to acquisitions as a means of making up for lost revenue. And one company they have their eye on is Seagen - a cancer drugmaker with a market cap of roughly $30 billion. Last year, Seagen was rumored to be acquired by Merck. This deal could [...]

9 01, 2023

Novavax Climbs 15% on New CEO Appointment – Before You Invest, Here are 3 Things to Consider

By |2023-12-07T21:05:17+00:00January 9th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , |

Monday morning started with a bang for Novavax, a company specializing in developing and selling vaccines - as the name suggests. They’ve played a role in discovering and rolling out vaccines for the seasonal flu, COVID-19, Ebola, and many other illnesses. And today, the company issued a statement announcing the appointment of John Jacobs [...]

5 01, 2023

Jazz Up your Portfolio in 2023

By |2023-12-07T21:05:22+00:00January 5th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , |

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was founded in 2003 and is incorporated and headquartered in Dublin, Ireland. JAZZ is a fully integrated, global biopharmaceutical company whose stated purpose is to provide innovative solutions and life-changing drugs to transform the lives of patients and their families across the globe, and result in longer lives. The [...]

3 01, 2023

Should You Buy Amgen Stock as Dividends are Set to Increase? 3 Things You Need to Account For

By |2023-12-07T21:05:45+00:00January 3rd, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , |

Amgen, a company known for pioneering modern biotechnology, has released information indicating they will be increasing the dividend from what was paid out last year. Executives stated that the payment will be $2.13 - which is 3.2% of the stock price.  Compared to the industry average for dividend payouts, this is quite impressive. But [...]

31 10, 2022

Actinium Pharmaceuticals (ATNM) Jumps 39% After Trial Results – Here’s What Investors Should Do…

By |2023-12-07T21:11:07+00:00October 31st, 2022|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , |

Actinium Pharmaceuticals (ATNM) is one of the biggest movers early Monday morning. The stock is up 39% for the day after the firm released news that their latest trial results were more than optimistic. The company specializes in developing targeted therapies for cancer. Their therapies are known as antibody radiation conjugates - a special [...]

28 09, 2022

What Biogen’s Alzheimer’s Drug Results Means for the Company’s Stock

By |2023-12-07T21:11:17+00:00September 28th, 2022|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , |

Yesterday, we discussed how Crispr stock enjoyed a short-lived jump ahead of seeking FDA approval for their gene therapy drug. But today, we’re here to talk about a drug company that has experienced a much larger spike as a result of positive news: Biogen. Biogen is engaged in discovering, developing, and delivering therapies for [...]

27 09, 2022

Crispr Stock Jumps after Seeking FDA Approval for Gene Therapy Drug…Should You Buy Now?

By |2023-12-07T21:11:17+00:00September 27th, 2022|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , |

While many stocks are moving downwards this morning, one stock has made a nice 5% jump since the market opened - and that’s Crispr.  The company is engaged in the development of transformative drugs based on gene therapy. And news just released that they are finally on the path to seeking FDA approval for [...]

23 09, 2022

LLY is Upgraded by Analysts Ahead of New Drug…But What Does VectorVest Rate the Stock?

By |2023-12-07T21:16:13+00:00September 23rd, 2022|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , |

You’d be hard-pressed to find a stock that’s shown positive growth over the past year - but Eli Lilly is one of them. The pharmaceutical developer & manufacturer has had a great year - up 35% in the last 365 days. Even looking at the bigger picture, this stock has been a high-performer. This [...]

Go to Top